World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03443817
Date of registration: 19/02/2018
Prospective Registration: Yes
Primary sponsor: University of Aarhus
Public title: Feasibility and Effect of a Follow up Tele-rehabilitation Program for Chronic Obstructive Lung Disease vs. Standard Follow up 2-TELEKOL
Scientific title: Feasibility and Effect of a Follow up Tele-rehabilitation Program for Chronic Obstructive Lung Disease vs. Standard Follow up
Date of first enrolment: March 1, 2018
Target sample size: 54
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03443817
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Denmark
Contacts
Name:     Jose Cerdan
Address: 
Telephone:
Email:
Affiliation:  Aarhus University Hospital
Name:     Jose Cerdan, PhD stud
Address: 
Telephone: +4530648283
Email: joscer@rm.dk
Affiliation: 
Name:     Jose Cerdan, PhD student
Address: 
Telephone: 30648283
Email: joscer@rm.dk
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Stable COPD

2. Signed informed consent

3. Completion of the standard rehabilitation program

4. Permanent oxygen therapy is not an obstacle for participation.

Exclusion Criteria:

1. The patient has significant musculoskeletal disorders that limit his / her function
levels to a degree that is not caused by dyspnea

2. The patient has pronounced dizziness, significant sensory or motor disability,
dementia or terminal malignant disease

3. Serious comorbidities (unstable heart disease, irregular diabetes, known malignant
disease, another disease that makes the patient unfit to participate in the study).

4. Non-compliant patient (eg. Nursing Homes Residents)

5. Participation in another project within the last 30 days

6. Mini-Mental State Examination score less than 24 points

7. Severe vision or hearing loss.

8. Non-Danish speaking.

9. Lack of will to implement the protocol.

10. Motor or sensory disease, which makes it impossible for walk training

11. Have experienced a worsening in the last 4-6 weeks

12. Musculoskeletal disorders

13. Serious heart diseases (ejection fraction <30%, daily angina, or as indicated by
treating the cardiologist)

14. Can not understand informed consent

15. Other factors that inhibit the use of telerehabilitation



Age minimum: 18 Years
Age maximum: 85 Years
Gender: All
Health Condition(s) or Problem(s) studied
Pulmonary Disease, Chronic Obstructive
Intervention(s)
Behavioral: Tele rehab
Primary Outcome(s)
6 minute walk test [Time Frame: measured at week 8]
Secondary Outcome(s)
health-related quality of life measured by SGRQ [Time Frame: 6 months after cessation]
6 minute walk test [Time Frame: 6 months after cessation]
Cost tele-rehab [Time Frame: 6 months]
Health-related quality of life [Time Frame: 8 weeks, and 6 months after cessation]
Generalised Anxiety Disorder Assessment (GAD-7) [Time Frame: 8 weeks, and 6 months after cessation]
Secondary ID(s)
2-KOL
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Eurostars
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history